A probiotic lozenge with Lactobacillus brevis CD2 that helps prevent and reduce oral mucositis in patients undergoing radiotherapy, chemotherapy, or Hematopoietic Stem Cell Transplantation (HSCT).
Cancer therapies like chemotherapy, radiotherapy, and stem cell transplants are vital for treatment, but they often cause severe side effects. One of the most painful conditions patients experience is oral mucositis—severe mouth ulcers and tissue inflammation that make eating, swallowing, and speaking extremely difficult. Beyond the physical discomfort, these painful lesions frequently force doctors to delay or interrupt crucial cancer treatments.
At Nexgen Pharma, we are dedicated to providing Oncology Supportive Care based solutions designed to help patients manage treatment-induced complications and maintain their therapy schedules with greater comfort.
A probiotic lozenge with Lactobacillus brevis CD2 that helps prevent and reduce oral mucositis in patients undergoing radiotherapy, chemotherapy, or Hematopoietic Stem Cell Transplantation (HSCT).
Rather than simply masking pain, Nexgen Pharma focuses on therapies that actively soothe and protect the oral mucosa. Utilizing specialized, clinically backed probiotic strains with powerful anti-inflammatory properties, these formulations help lower nitric oxide levels, calm tissue swelling, and preserve the oral lining during aggressive cancer treatments.
Delivered as smooth oral probiotic lozenges, these beneficial bacteria provide direct, localized action on sensitive mouth tissues. Utilizing probiotic lozenges offers a practical, gentle solution for individuals struggling with swallowing difficulties or dry mouth.
Targeted Mucositis Care: Recognized among the best probiotics for chemo-radiotherapy mucosisits, helping reduce the risk of severe ulcers before treatment starts and aiding the healing of existing lesions.
Pain & Inflammation Relief: Significantly eases oral soreness, allowing patients to swallow and maintain proper nutrition.
Uninterrupted Therapy: Helps prevent treatment delays, allowing oncology teams to keep chemotherapy and radiation schedules on track.
Enhanced Comfort in Advanced Care: Serves as effective probiotics for pallative care in cancer, boosting daily Quality of Life (QoL) and overall well-being.
Nexgen Pharma remains committed to advancing supportive cancer care—helping patients manage side effects, regain comfort, and focus on their path to recovery.
